126 related articles for article (PubMed ID: 2153051)
1. Identification of B16-F1 melanoma autocrine motility-like factor receptor.
Nabi IR; Watanabe H; Raz A
Cancer Res; 1990 Jan; 50(2):409-14. PubMed ID: 2153051
[TBL] [Abstract][Full Text] [Related]
2. Purification of B16-F1 melanoma autocrine motility factor and its receptor.
Silletti S; Watanabe H; Hogan V; Nabi IR; Raz A
Cancer Res; 1991 Jul; 51(13):3507-11. PubMed ID: 1647268
[TBL] [Abstract][Full Text] [Related]
3. The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells.
Watanabe H; Nabi IR; Raz A
Cancer Res; 1991 May; 51(10):2699-705. PubMed ID: 2021948
[TBL] [Abstract][Full Text] [Related]
4. Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Timar J; Trikha M; Szekeres K; Bazaz R; Tovari J; Silletti S; Raz A; Honn KV
Cancer Res; 1996 Apr; 56(8):1902-8. PubMed ID: 8620512
[TBL] [Abstract][Full Text] [Related]
5. Suppression of melanoma cell motility factor receptor expression by retinoic acid.
Lotan R; Amos B; Watanabe H; Raz A
Cancer Res; 1992 Sep; 52(18):4878-84. PubMed ID: 1325286
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization.
Nicolson GL; Inoue T; Van Pelt CS; Cavanaugh PG
Cancer Res; 1990 Feb; 50(3):515-20. PubMed ID: 2297694
[TBL] [Abstract][Full Text] [Related]
7. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell autocrine motility factor receptor.
Nabi IR; Watanabe H; Silletti S; Raz A
EXS; 1991; 59():163-77. PubMed ID: 1655517
[TBL] [Abstract][Full Text] [Related]
9. Loss of metastatic responsiveness to cell shape modulation in a newly characterized B16 melanoma adhesive cell variant.
Nabi IR; Raz A
Cancer Res; 1988 Mar; 48(5):1258-64. PubMed ID: 3342405
[TBL] [Abstract][Full Text] [Related]
10. Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
Nabi IR; Watanabe H; Raz A
Cancer Metastasis Rev; 1992 Mar; 11(1):5-20. PubMed ID: 1324804
[TBL] [Abstract][Full Text] [Related]
11. Heregulin regulation of autocrine motility factor expression in human tumor cells.
Talukder AH; Adam L; Raz A; Kumar R
Cancer Res; 2000 Jan; 60(2):474-80. PubMed ID: 10667603
[TBL] [Abstract][Full Text] [Related]
12. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
Herd ZL
Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Watanabe H; Takehana K; Date M; Shinozaki T; Raz A
Cancer Res; 1996 Jul; 56(13):2960-3. PubMed ID: 8674049
[TBL] [Abstract][Full Text] [Related]
14. [The role of autocrine motility factor receptor in metastasis].
Watanabe H; Chigira M; Raz A
Gan To Kagaku Ryoho; 1993 Feb; 20(3):405-9. PubMed ID: 8382466
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-phosphate regulates melanoma cell motility through a receptor-coupled extracellular action and in a pertussis toxin-insensitive manner.
Yamamura S; Yatomi Y; Ruan F; Sweeney EA; Hakomori S; Igarashi Y
Biochemistry; 1997 Sep; 36(35):10751-9. PubMed ID: 9271506
[TBL] [Abstract][Full Text] [Related]
16. Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
Niinaka Y; Paku S; Haga A; Watanabe H; Raz A
Cancer Res; 1998 Jun; 58(12):2667-74. PubMed ID: 9635595
[TBL] [Abstract][Full Text] [Related]
17. G-protein involvement in matrix-mediated motility and invasion of high and low experimental metastatic B16 melanoma clones.
Lester BR; McCarthy JB; Sun ZQ; Smith RS; Furcht LT; Spiegel AM
Cancer Res; 1989 Nov; 49(21):5940-8. PubMed ID: 2477150
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor.
Hendrix MJ; Wood WR; Seftor EA; Lotan D; Nakajima M; Misiorowski RL; Seftor RE; Stetler-Stevenson WG; Bevacqua SJ; Liotta LA
Cancer Res; 1990 Jul; 50(13):4121-30. PubMed ID: 2162253
[TBL] [Abstract][Full Text] [Related]
19. Expression of constitutively activated hepatocyte growth factor/scatter factor receptor (c-met) in B16 melanoma cells selected for enhanced liver colonization.
Rusciano D; Lorenzoni P; Burger MM
Oncogene; 1995 Nov; 11(10):1979-87. PubMed ID: 7478516
[TBL] [Abstract][Full Text] [Related]
20. Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis.
Watanabe H; Shinozaki T; Raz A; Chigira M
Int J Cancer; 1993 Feb; 53(4):689-95. PubMed ID: 8382196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
